Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
- PMID: 32738491
- PMCID: PMC7388856
- DOI: 10.1016/j.ijid.2020.07.056
Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
Comment in
-
A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19.Int J Infect Dis. 2020 Oct;99:138-139. doi: 10.1016/j.ijid.2020.07.059. Epub 2020 Jul 31. Int J Infect Dis. 2020. PMID: 32745629 Free PMC article. No abstract available.
-
The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.Int J Infect Dis. 2020 Nov;100:25-26. doi: 10.1016/j.ijid.2020.08.058. Epub 2020 Aug 27. Int J Infect Dis. 2020. PMID: 32861824 Free PMC article. No abstract available.
Comment on
-
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2. Int J Infect Dis. 2020. PMID: 32623082 Free PMC article.
References
-
- Horby P., Lim W.S., Emberson J., Mafham M., Bell J.L., Linsell L. 2020. Effect of desamethasone in hospitalized patients with CVID-19: preliminary report. COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv.